Profiel
Daniel L.
Kisner is currently Chairman at Idun Pharmaceuticals, Inc., Director at Lpath Therapeutics, Inc., and Independent Director at Oncternal Therapeutics, Inc. since 2019.
Former roles include Chairman at Caliper Life Sciences, Inc. from 2002 to 2008; Chairman at Sequoia Pharmaceuticals, Inc.; Chairman at Avera Pharmaceuticals, Inc.; Chairman at Caliper Technologies Corp.
from 2003 to 2008; Chairman at Arbutus Biopharma Corp.
from 2010 to 2015; Director at Pfizer Inc.; Director at Sequenom, Inc.; Director at Kémia, Inc.; Director at Tolerx, Inc. from 2001 to 2011; Director at EMulate Therapeutics, Inc.; Director at KAI Pharmaceuticals, Inc.; Independent Director at Conatus Pharmaceuticals, Inc.; Director at Adaptive Therapeutics, Inc.; Independent Director at Lpath, Inc. from 2012 to 2016; Director at MPEX Pharmaceuticals, Inc.; Director at Symphony Allegro, Inc.; Independent Director at Dynavax Technologies Corp.
from 2010 to 2026; Independent Director at Zynerba Pharmaceuticals, Inc.; Independent Director at Histogen, Inc. from 2014 to 2023; Director at Oncternal Oncology, Inc.; Vice President-Pharmaceutical Development at Abbott Laboratories from 1988 to 1991; President & Chief Operating Officer at Ionis Pharmaceuticals, Inc. from 1991 to 1999; Partner at Aberdare Management Co. LLC.
from 2003 to 2011; Vice President-Clinical Research & Development at Smithkline Beckman Corp from 1985 to 1988.
Education includes undergraduate studies at Rutgers State University of New Jersey and a doctorate from Georgetown University conferred in 1972.
Actieve functies van Dan Kisner
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Directeur/Bestuurslid | 07-06-2019 |
Lpath Therapeutics, Inc.
Lpath Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases | Directeur/Bestuurslid | - |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutics and conducts medical research | Voorzitter | - |
Eerdere bekende functies van Dan Kisner
| Bedrijven | Functie | Einde |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Directeur/Bestuurslid | 10-02-2026 |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Discovers and develops lipidomic-based therapeutic antibodies | Directeur/Bestuurslid | 01-12-2016 |
| ARBUTUS BIOPHARMA CORPORATION | Voorzitter | 01-03-2015 |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops drugs and therapies | Voorzitter | 08-07-2013 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Directeur/Bestuurslid | 19-12-2011 |
Opleiding van Dan Kisner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 29 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells lab chip systems | Health Technology |
Sequenom, Inc.
Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Sequoia Pharmaceuticals, Inc.
Sequoia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antiviral therapeutics | Health Technology |
Kémia, Inc.
Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Health Technology |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops drugs and therapies | Health Services |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutics and conducts medical research | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage health technology company which develops non-invasive therapies for cancers and neuropsychiatric conditions | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Conatus Pharmaceuticals, Inc.
Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of human therapeutics to treat liver diseases | Health Technology |
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Aberdare Ventures
Aberdare Ventures Investment ManagersFinance Aberdare Ventures invests in companies located in the United States. The firm focuses on the healthcare technology sector. It participates in early-stage transactions with an investment size of USD 1 - 15 million. It makes co-investments. | Finance |
Smithkline Beckman Corp
Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Therapeutics, Inc.
Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Lpath Therapeutics, Inc.
Lpath Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases | Health Technology |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Discovers and develops lipidomic-based therapeutic antibodies | Health Technology |
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Commercial Services |
Caliper Technologies Corp.
Caliper Technologies Corp. Medical SpecialtiesHealth Technology A leading provider of microfluidic technology and laboratory automation solutions serving a broad range of markets in the worldwide life science, biotechnology and pharmaceutical industries. | Health Technology |
Symphony Allegro, Inc.
Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical drugs | Health Technology |
Oncternal Oncology, Inc.
Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company and manufactures pharmaceutical products | Health Technology |
Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Histogen, Inc.
Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
















